Crossmark

Evaluation of the safety profile of glucagon-like peptide-1 receptor agonists: a focus on thyroid cancer-related adverse events by using the European pharmacovigilance database

Crossref DOI link: https://doi.org/10.1007/s43440-026-00864-4

Published Online: 2026-05-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Anatriello, Antonietta

Liguori, Valerio

Pentella, Ciro

Zinzi, Alessia https://orcid.org/0000-0002-9425-9923
Longo, Miriam

Caruso, Paola

Maiorino, Maria Ida

Esposito, Katherine

Capuano, Annalisa
Funding

Funding for this research was provided by:

Università degli Studi della Campania Luigi Vanvitelli
License Information

Text and Data Mining valid from 2026-05-28

Version of Record valid from 2026-05-28
More Information

Article History

Received: 3 July 2025

Revised: 2 May 2026

Accepted: 4 May 2026

First Online: 28 May 2026

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below